🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study of ABT-267 in both healthy volunteers and Hepatitis C virus (HCV) gen...
Status
Completed
Location
Site Reference ID/Investigator# 42708
Start Date
2010-08
Trial ID
NCT01181427
Treatments Being Tested
The primary objective of this study is to evaluate the pharmacokinetics (PK...
Status
Completed
Location
Site 01
Start Date
2023-01-24
Trial ID
NCT05712265
Treatments Being Tested
The purpose of this study is to define and compare the pharmacokinetic (PK)...
Status
Recruiting
Location
Eurofins Optimed
Start Date
2025-10-28
Trial ID
NCT07251153
To evaluate the effect of itraconazole/rifampicin on the pharmacokinetics o...
Status
Not Yet Recruiting
Location
Beijing Tongren Hospital Affiliated to Capital Medical University
Start Date
2024-11
Trial ID
NCT06662773
Treatments Being Tested
Lewy body spectrum disorders are a common group of neurodegenerative diseas...
Status
Completed
Location
Sunnybrook Health Sciences Centre
Start Date
2006-09
Trial ID
NCT01944436
Treatments Being Tested
RATIONALE: Biological therapies such as gefitinib may interfere with the gr...
Status
Completed
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2001-10-09
Trial ID
NCT00025675
Treatments Being Tested
The purpose of this study is to evaluate the effects of multiple doses of G...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-09
Trial ID
NCT00966966
Treatments Being Tested
This study will be a single center, open-label, 2-period, fixed-sequence, P...
Status
Completed
Location
Covance Research Unit - Dallas
Start Date
2017-07-18
Trial ID
NCT03222310
Treatments Being Tested
This is a single-center, randomized, open-label, 3 parallel treatment study...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01
Trial ID
NCT01754116
The purpose of this study is to evaluate the effect of the potent CYP3A4 in...
Status
Completed
Location
Pharmaceutical Research Associates, Inc.
Start Date
2017-05-31
Trial ID
NCT03173170
Treatments Being Tested